Global Morcellators Market, By Type (Electric Morcellator, Manual Morcellator, and Others), Application (Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Others), Usage Type (Reusable, Reposable, and Disposable), End Use (Uterine Fibroids, Hysteroscopy, Laparoscopy, and Others) – Industry Trends and Forecast to 2029.
Morcellators Market Analysis and Size
A class II medical device called a morcellator which is utilised during laparoscopic surgeries. Laparoscopes can be used to remove the smaller fragments of tissue. Morcellation is a minimally invasive procedure that enables surgeons to carry out a variety of operations through a small incision. The two main drivers most likely to shoot the expansion of the morcellators market during the forecast period are the rise in preference for minimally invasive gynaecological and other surgical procedures, and the rise in public awareness of cutting-edge surgical tools.
Data Bridge Market Research analyses that the morcellators market which was USD 115 million in 2021, would rocket up to USD 205.10 million by 2029, and is expected to undergo a CAGR of 7.50 % during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Morcellators Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (Electric Morcellator, Manual Morcellator, and Others), Application (Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Others), Usage Type (Reusable, Reposable, and Disposable), End Use (Uterine Fibroids, Hysteroscopy, Laparoscopy, and Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Johnson & Johnson Private Limited (U.S.), Blue Endo (U.S.), Karl Storz (Germany), Richard Wolf GmbH (Germany), FemRx Templeton (U.S.), Lumenis Be LTD. (Israel), Hologic Inc. (U.S.), Smith+Nephew (U.S.), Olympus Corporation (Japan), Nouvag (Germany), LiNA Medical ApS (Denmark), Medtronic (Ireland), Stryker (U.S.), C. R. Bard, Inc. (U.S.), Cook Urological, Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
During laparoscopic surgery, a morcellator is a surgical tool that allows doctors to divide a bigger piece of tissue into smaller ones. Surgeons mostly use them for gynaecological treatments such laparoscopic hysterectomy and myomectomy (removal of the ovaries) (fibroid removal). Additionally, a morcellator is utilised during liver, spleen, and gallbladder surgeries.
Morcellators Market Dynamics
Drivers
- Increase in the preference for minimally invasive procedures
The key drivers projected to foster the growth of the morcellators industry throughout the forecast period include an increase in the preference for minimally invasive procedures like gynaecological and other operational methods and an increase in public awareness of high-level operational tools.
- Increased prevalence of uterine fibroids
The factors driving the morcellator market expansion throughout the forecast period include the increased prevalence of uterine fibroids among womens globally, the growing inclination for minimally invasive gynaecological operations, and technical advancements in surgical equipment.
Opportunities
Smaller incisions allow for quicker healing and less postoperative pain, therefore, these operations are becoming increasingly popular. To remove bigger fibroids, surgeons now use single-port laparoscopic and robotic myomectomies/hysterectomies. These can be removed by making small incisions and chopping them into pieces with power morcellators. Minimally invasive techniques therefore carry a lower risk of blood loss and infection than open abdominal surgery. Therefore, it is anticipated that an increase in hysterectomy procedures would fuel the expansion of the morcellator market throughout the course of the forecast period.
Restraints/Challenges
On the other hand, the high cost associated with drug development and distribution will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market.
This morcellators market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the morcellators market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Morcellators Market
Due to the marketplace's closure, demand and supply for raw materials and the production and delivery of goods have all been severely disrupted. The transportation, aviation, oil and gas, and electronic sectors have all seen significant financial losses. Morcellators are one of the items and components whose demand has decreased as a result of this. All of these factors have been thoroughly examined in this paper.
Global Morcellators Market Scope
The morcellators market is segmented on the basis of type, application, usage type and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Electric Morcellator
- Manual Morcellator
- Others
Application
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Usage Type
- Reusable
- Reposable
- Disposable
End Use
- Uterine Fibroids
- Hysteroscopy
- Laparoscopy
- Others
Morcellators Market Regional Analysis/Insights
The morcellators market is analysed and market size insights and trends are provided by country, type, application, usage type and end use as referenced above.
The countries covered in the morcellators market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the morcellators market due to the good healthcare foundation and laparoscopic technological advancements.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Morcellators Market Share Analysis
The morcellators market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to morcellators market.
Some of the major players operating in the morcellators market are:
- Johnson & Johnson Private Limited (U.S.)
- Blue Endo (U.S.)
- Karl Storz (Germany)
- Richard Wolf GmbH (Germany)
- FemRx Templeton (U.S.)
- Lumenis Be LTD. (Israel)
- Hologic Inc. (U.S.)
- Smith+Nephew (U.S.)
- Olympus Corporation (Japan)
- Nouvag (Germany)
- LiNA Medical ApS (Denmark)
- Medtronic (Ireland)
- Stryker (U.S.)
- C. R. Bard, Inc. (U.S.)
- Cook Urological, Inc. (U.S.)
SKU-
